Cart
sales@molnova.com
Glutathione synthesis-IN-1
CAS No. 2632968-72-8
Glutathione synthesis-IN-1( —— )
Catalog No. M37706 CAS No. 2632968-72-8
Glutathione synthesis-IN-1 (DC-1) is an inhibitor of glutathione synthesis.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 144 | In Stock |
|
| 10MG | 215 | In Stock |
|
| 25MG | 335 | In Stock |
|
| 50MG | 443 | In Stock |
|
| 100MG | 607 | In Stock |
|
| 200MG | 817 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameGlutathione synthesis-IN-1
-
NoteResearch use only, not for human use.
-
Brief DescriptionGlutathione synthesis-IN-1 (DC-1) is an inhibitor of glutathione synthesis.
-
DescriptionGlutathione synthesis-IN-1 (DC-1) is a glutathione synthesis inhibitor.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2632968-72-8
-
Formula Weight316.35
-
Molecular FormulaC21H16O3
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 50 mg/mL (158.05 mM; Ultrasonic )
-
SMILESOC(=O)c1cc(\C=C\c2ccc(cc2)-c2ccccc2)ccc1O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Hans-René BJ?RSVIK, et al. Therapy. WO2021058979A1.
molnova catalog
related products
-
1-Indanone
The intermediate od Indinavir.
-
α-ANF(1-28), human
Atrial natriuretic factor (1-28) (human, porcine) exhibits blood pressure lowering activity by increasing sodium and urine excretion. Atrial natriuretic factor (1-28) (human, porcine) inhibits the release of pituitary adrenocorticotropic hormone (ACTH) and beta-endorphin through inhibition of pro-opiomelanocortin (POMC) expression. Atrial natriuretic factor (1-28) (human, porcine) increases cGMP levels in RMIC cells with an IC50 of 1.2 nM.
-
FTIDC
FTIDC is a highly potent and selective allosteric antagonist of mGluR1 receptors and shows very weak potency against human and rat mGluR5 receptors.
